12.5mg sunitinib with Cisplatin and Gemcitabine
NP01/27/10
Phase 2 small_molecule completed
Quick answer
12.5mg sunitinib with Cisplatin and Gemcitabine for Nasopharyngeal Carcinoma is a Phase 2 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Nasopharyngeal Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed